vs
Side-by-side financial comparison of AGENUS INC (AGEN) and Community West Bancshares (CWBC). Click either name above to swap in a different company.
Community West Bancshares is the larger business by last-quarter revenue ($38.3M vs $34.2M, roughly 1.1× AGENUS INC). On growth, AGENUS INC posted the faster year-over-year revenue change (27.5% vs 11.6%). Over the past eight quarters, Community West Bancshares's revenue compounded faster (36.0% CAGR vs 10.5%).
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.
Community West BancsharesCWBCEarnings & Financial Report
Community West Bancshares is a registered bank holding company headquartered in California. It wholly owns Community West Bank under the Bank Holding Company Act.
AGEN vs CWBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.2M | $38.3M |
| Net Profit | $-10.6M | — |
| Gross Margin | — | — |
| Operating Margin | 42.1% | 40.0% |
| Net Margin | -31.0% | — |
| Revenue YoY | 27.5% | 11.6% |
| Net Profit YoY | 77.3% | — |
| EPS (diluted) | $0.09 | $0.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.2M | $38.3M | ||
| Q3 25 | $30.2M | $37.9M | ||
| Q2 25 | $25.7M | $35.7M | ||
| Q1 25 | $24.1M | $34.8M | ||
| Q4 24 | $26.8M | $34.3M | ||
| Q3 24 | $25.1M | $31.3M | ||
| Q2 24 | $23.5M | $30.5M | ||
| Q1 24 | $28.0M | $20.7M |
| Q4 25 | $-10.6M | — | ||
| Q3 25 | $63.9M | $10.9M | ||
| Q2 25 | $-30.0M | $7.8M | ||
| Q1 25 | $-26.4M | $8.3M | ||
| Q4 24 | $-46.8M | — | ||
| Q3 24 | $-67.2M | $3.4M | ||
| Q2 24 | $-54.8M | $-6.3M | ||
| Q1 24 | $-63.5M | $3.7M |
| Q4 25 | — | — | ||
| Q3 25 | 97.9% | — | ||
| Q2 25 | 99.1% | — | ||
| Q1 25 | 99.4% | — | ||
| Q4 24 | 99.6% | — | ||
| Q3 24 | 99.4% | — | ||
| Q2 24 | 99.5% | — | ||
| Q1 24 | 99.6% | — |
| Q4 25 | 42.1% | 40.0% | ||
| Q3 25 | -15.0% | 39.8% | ||
| Q2 25 | -65.0% | 30.2% | ||
| Q1 25 | -55.3% | 32.7% | ||
| Q4 24 | -96.5% | 31.0% | ||
| Q3 24 | -125.5% | 13.3% | ||
| Q2 24 | -128.4% | -25.9% | ||
| Q1 24 | -117.4% | 23.2% |
| Q4 25 | -31.0% | — | ||
| Q3 25 | 211.4% | 28.7% | ||
| Q2 25 | -116.8% | 22.0% | ||
| Q1 25 | -109.6% | 23.8% | ||
| Q4 24 | -174.4% | — | ||
| Q3 24 | -267.7% | 10.8% | ||
| Q2 24 | -233.1% | -20.7% | ||
| Q1 24 | -226.6% | 17.8% |
| Q4 25 | $0.09 | $0.58 | ||
| Q3 25 | $1.94 | $0.57 | ||
| Q2 25 | $-1.00 | $0.41 | ||
| Q1 25 | $-1.03 | $0.44 | ||
| Q4 24 | $-1.95 | $0.29 | ||
| Q3 24 | $-3.08 | $0.18 | ||
| Q2 24 | $-2.52 | $-0.33 | ||
| Q1 24 | $-3.04 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | $119.0M |
| Total DebtLower is stronger | $44.7M | $69.5M |
| Stockholders' EquityBook value | $-271.1M | $409.6M |
| Total Assets | $226.8M | $3.7B |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $119.0M | ||
| Q3 25 | $3.5M | $121.6M | ||
| Q2 25 | $9.5M | $134.4M | ||
| Q1 25 | $18.5M | $148.4M | ||
| Q4 24 | $40.4M | $120.4M | ||
| Q3 24 | $44.8M | $149.0M | ||
| Q2 24 | $93.7M | $109.7M | ||
| Q1 24 | $52.9M | $61.0M |
| Q4 25 | $44.7M | $69.5M | ||
| Q3 25 | $34.2M | — | ||
| Q2 25 | $33.9M | — | ||
| Q1 25 | $33.6M | — | ||
| Q4 24 | $33.2M | $69.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-271.1M | $409.6M | ||
| Q3 25 | $-274.1M | $397.6M | ||
| Q2 25 | $-354.6M | $380.0M | ||
| Q1 25 | $-341.8M | $372.2M | ||
| Q4 24 | $-326.4M | $362.7M | ||
| Q3 24 | $-292.3M | $363.5M | ||
| Q2 24 | $-241.3M | $350.2M | ||
| Q1 24 | $-201.4M | $211.7M |
| Q4 25 | $226.8M | $3.7B | ||
| Q3 25 | $233.9M | $3.6B | ||
| Q2 25 | $185.2M | $3.6B | ||
| Q1 25 | $200.2M | $3.6B | ||
| Q4 24 | $226.3M | $3.5B | ||
| Q3 24 | $238.5M | $3.5B | ||
| Q2 24 | $292.4M | $3.5B | ||
| Q1 24 | $256.6M | $2.4B |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.6M | $46.1M |
| Free Cash FlowOCF − Capex | — | $43.6M |
| FCF MarginFCF / Revenue | — | 113.9% |
| Capex IntensityCapex / Revenue | 0.0% | 6.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $77.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.6M | $46.1M | ||
| Q3 25 | $-14.7M | $13.2M | ||
| Q2 25 | $-20.2M | $11.5M | ||
| Q1 25 | $-25.6M | $11.1M | ||
| Q4 24 | $-28.7M | $22.2M | ||
| Q3 24 | $-53.3M | $7.8M | ||
| Q2 24 | $-38.2M | $5.2M | ||
| Q1 24 | $-38.2M | $4.0M |
| Q4 25 | — | $43.6M | ||
| Q3 25 | — | $12.8M | ||
| Q2 25 | $-20.2M | $10.6M | ||
| Q1 25 | $-25.6M | $10.8M | ||
| Q4 24 | $-28.7M | $17.2M | ||
| Q3 24 | $-53.3M | $5.2M | ||
| Q2 24 | $-38.6M | $4.8M | ||
| Q1 24 | $-38.2M | $3.6M |
| Q4 25 | — | 113.9% | ||
| Q3 25 | — | 33.7% | ||
| Q2 25 | -78.7% | 29.6% | ||
| Q1 25 | -106.5% | 30.9% | ||
| Q4 24 | -107.0% | 50.0% | ||
| Q3 24 | -212.2% | 16.7% | ||
| Q2 24 | -164.4% | 15.7% | ||
| Q1 24 | -136.5% | 17.3% |
| Q4 25 | 0.0% | 6.6% | ||
| Q3 25 | 0.0% | 1.1% | ||
| Q2 25 | 0.0% | 2.7% | ||
| Q1 25 | 0.0% | 0.9% | ||
| Q4 24 | 0.3% | 14.7% | ||
| Q3 24 | 0.0% | 8.1% | ||
| Q2 24 | 2.0% | 1.4% | ||
| Q1 24 | 0.1% | 2.1% |
| Q4 25 | — | — | ||
| Q3 25 | -0.23× | 1.21× | ||
| Q2 25 | — | 1.47× | ||
| Q1 25 | — | 1.33× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.29× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGEN
| Non Cash Royalty Revenue | $31.1M | 91% |
| Other | $3.2M | 9% |
CWBC
Segment breakdown not available.
